PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35501389-5	2022	RESULTS: Expression of X-linked inhibitor of apoptosis (XIAP) is increased in BRCA1-mutated cancers and high levels are associated with improved patient outcomes after platinum chemotherapy.	Platinum	168-176	X-linked inhibitor of apoptosis	Homo sapiens	23-54	
34716858-5	2022	XIAP was found to contribute to developing platinum resistance and is an authentic target for miR-874-3p in SKOV3-DDP cells.	Platinum	43-51	X-linked inhibitor of apoptosis	Homo sapiens	0-4	
35501389-5	2022	RESULTS: Expression of X-linked inhibitor of apoptosis (XIAP) is increased in BRCA1-mutated cancers and high levels are associated with improved patient outcomes after platinum chemotherapy.	Platinum	168-176	X-linked inhibitor of apoptosis	Homo sapiens	56-60	
32703189-14	2020	Exposure to PT resulted in the downregulation of anti-apoptotic proteins (Bcl2, BclxL, XIAP) and alteration in Cyclins expression.	Platinum	12-14	X-linked inhibitor of apoptosis	Homo sapiens	87-91	
31635307-0	2019	ATM Regulated PTEN Degradation Is XIAP E3 Ubiquitin Ligase Mediated in p85alpha Deficient Cancer Cells and Influence Platinum Sensitivity.	Platinum	117-125	X-linked inhibitor of apoptosis	Homo sapiens	34-38	
31635307-15	2019	In ovarian cancer patients, ATM, PTEN, p85alpha, and XIAP protein levels predicted better progression free survival after platinum therapy.	Platinum	122-130	X-linked inhibitor of apoptosis	Homo sapiens	53-57	
18719365-5	2008	Further analysis revealed that the sensitization of platinums was associated with platinums-induced suppression of nuclear factor-kappaB (NFkappaB) and subsequent downregulation of X-linked inhibitor of apoptosis protein (XIAP), which rescued caspase-3 from inhibition.	Platinum	52-61	X-linked inhibitor of apoptosis	Homo sapiens	181-220	
18719365-5	2008	Further analysis revealed that the sensitization of platinums was associated with platinums-induced suppression of nuclear factor-kappaB (NFkappaB) and subsequent downregulation of X-linked inhibitor of apoptosis protein (XIAP), which rescued caspase-3 from inhibition.	Platinum	52-61	X-linked inhibitor of apoptosis	Homo sapiens	222-226	
18719365-5	2008	Further analysis revealed that the sensitization of platinums was associated with platinums-induced suppression of nuclear factor-kappaB (NFkappaB) and subsequent downregulation of X-linked inhibitor of apoptosis protein (XIAP), which rescued caspase-3 from inhibition.	Platinum	82-91	X-linked inhibitor of apoptosis	Homo sapiens	181-220	
18719365-5	2008	Further analysis revealed that the sensitization of platinums was associated with platinums-induced suppression of nuclear factor-kappaB (NFkappaB) and subsequent downregulation of X-linked inhibitor of apoptosis protein (XIAP), which rescued caspase-3 from inhibition.	Platinum	82-91	X-linked inhibitor of apoptosis	Homo sapiens	222-226	
24853184-2	2014	The aim of this study is to evaluate the impact of XIAP expression upon ovarian clear cell carcinoma (CCC) that has a platinum-resistant phenotype.	Platinum	118-126	X-linked inhibitor of apoptosis	Homo sapiens	51-55	
24853184-6	2014	Cases with high XIAP expression had lower response rate to primary platinum-based chemotherapy (10% vs 65%, P=0.02).	Platinum	67-75	X-linked inhibitor of apoptosis	Homo sapiens	16-20